DARE
NASDAQ · Pharmaceuticals
Dare Bioscience Inc
$1.36
+0.06 (+4.62%)
Open$1.32
Previous Close$1.30
Day High$1.36
Day Low$1.27
52W High$9.19
52W Low$1.27
Volume—
Avg Volume59.6K
Market Cap18.58M
P/E Ratio—
EPS$-1.47
SectorPharmaceuticals
Analyst Ratings
Strong Buy
10 analysts
Price Target
+202.9% upside
Current
$1.36
$1.36
Target
$4.12
$4.12
$2.96
$4.12 avg
$5.49
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 17.1K | 6.97M | 6.37M |
| Net Income | -6,815,961 | 1.03M | 1.14M |
| Profit Margin | -41,447.9% | 14.8% | 17.9% |
| EBITDA | -6,745,944 | 1.81M | 1.58M |
| Free Cash Flow | — | 730.8K | 772.3K |
| Rev Growth | — | +17.6% | +7.5% |
| Debt/Equity | — | 0.70 | 0.72 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |